How is it possible... ...that we sent people to the moon almost 50 years ago, yet millions of people with tuberculosis are still treated with old, inadequate medicines? https://tbsummit.msfaccess.org/
Infographics: Hepatitis C Filter by - Any -CampaignEventsFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementStoryTechnical briefThe issuesTopic overviewVideo Technical brief Technical brief | 11 March 2019 Hepatitis C MSF Access Campaign analysis of the MPP Licence Agreement with AbbVie for glecaprevir/pibrentasvir (G/P) Technical brief | 07 March 2019 Hepatitis C MPP licence agreement with AbbVie for glecaprevir/pibrentasvir Letter Letter | 11 February 2019 Hepatitis C Malaysia Malaysia’s compulsory licence for sofosbuvir is a positive step for public health and innovation Press release Press release | 05 December 2018 Hepatitis C Health groups appeal European Patent Office decision to uphold Gilead’s patent on hepatitis C drug 3 min Load More Tags Hepatitis C
Technical brief Technical brief | 11 March 2019 Hepatitis C MSF Access Campaign analysis of the MPP Licence Agreement with AbbVie for glecaprevir/pibrentasvir (G/P)
Technical brief | 07 March 2019 Hepatitis C MPP licence agreement with AbbVie for glecaprevir/pibrentasvir
Letter Letter | 11 February 2019 Hepatitis C Malaysia Malaysia’s compulsory licence for sofosbuvir is a positive step for public health and innovation
Press release Press release | 05 December 2018 Hepatitis C Health groups appeal European Patent Office decision to uphold Gilead’s patent on hepatitis C drug 3 min
